CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-13 | Burek Julie VP, Finance | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-01-13 | Hesslein Robert W. Senior VP & General Counsel | Grant or award | +20,000 | 130,056 | ||
| 2022-01-13 | Hesslein Robert W. Senior VP & General Counsel | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2022-01-13 | PIERCE GLENN Interim CSO | Grant or award | +26,300 | 26,300 | ||
| 2022-01-13 | PIERCE GLENN Interim CSO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-01-13 | Higgins Michael J Interim President & CEO | Grant or award | +45,205 | 45,205 | ||
| 2022-01-13 | Higgins Michael J Interim President & CEO | Grant or award · Stock Option (Right to Buy) | +161,000 | 161,000 | ||
| 2022-01-12 | Burek Julie VP, Finance | Sale | −265 | $3.06 | $811 | 46,257 |
| 2022-01-03 | Burek Julie VP, Finance | Sale | −3,063 | $2.83 | $9K | 46,522 |
| 2021-12-31 | Burek Julie VP, Finance | Grant or award | +3,063 | $2.30 | $7K | 49,585 |
| 2021-11-26 | Burek Julie VP, Finance | Grant or award | +13,500 | 46,522 | ||
| 2021-11-26 | Burek Julie VP, Finance | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-06-07 | PIERCE GLENN Interim CSO | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | ||
| 2021-06-03 | Vitale Nancy Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-03 | PAUL STEVEN M Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-03 | Hyman Steven Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-03 | Higgins Michael J Interim President & CEO | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2021-06-03 | LEVIN MARK J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-03 | GERAGHTY JAMES A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-03 | PIERCE GLENN Interim CSO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 11 of 19 · 368 trades